SONIRE Therapeutics Inc.
2 clinical trials · Sponsor
◉ Watch SONIRE Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II) (NCT07033689) | SONIRE Therapeutics Inc. | 2026-01-05 |
| A Study of Suizenji in Patients With Unresectable Pancreatic Cancer (NCT05601323) | SONIRE Therapeutics Inc. | 2023-01-31 |
Track SONIRE Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.